Breaking News Instant updates and real-time market news.

NUGT

Direxion Gold Miners Bull

$15.40

(0.00%)

, NIO

NIO Inc.

$7.43

(0.00%)

09:40
10/15/18
10/15
09:40
10/15/18
09:40

Unusually active option classes on open October 15th

Unusual total active option classes on open include: Direxion Daily Gold Miners Bull 3X Shares (NUGT), NIO Inc (NIO), SPDR Gold Trust (GLD), Direxion Junior Gold (JNUG), GDM (GDX), Home Depot (HD), United States Oil Fund (USO), and Chesapeake (CHK).

NUGT

Direxion Gold Miners Bull

$15.40

(0.00%)

NIO

NIO Inc.

$7.43

(0.00%)

GLD

SPDR Gold Shares

$115.24

(0.00%)

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$8.94

(0.00%)

GDX

VanEck Vectors Gold Miners ETF

$19.75

(0.00%)

HD

Home Depot

$192.24

(0.00%)

USO

United States Oil Fund

$15.12

(0.00%)

CHK

Chesapeake

$4.45

(0.00%)

NUGT Direxion Gold Miners Bull
$15.40

(0.00%)

NIO NIO Inc.
$7.43

(0.00%)

10/09/18
10/09/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tesla (TSLA) initiated with an Outperform at Macquarie. 2. Tellurian (TELL) initiated with a Buy at BofA/Merrill. 3. NIO Inc. (NIO) initiated with a Neutral at JPMorgan and an Overweight at Morgan Stanley. 4. Eyenovia (EYEN) initiated with a Buy at H.C. Wainwright. 5. Garrett Motion (GTX) initiated with an Equal Weight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/09/18
MSCO
10/09/18
INITIATION
Target $8.5
MSCO
Overweight
NIO Inc. initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Jack Yeung initiated NIO Inc. with an Overweight rating and $8.50 price target, projecting a sales volume CAGR of 54.5% in 2017-22 for China's premium EV market and contending that NIO's price advantage over foreign competitors will allow it to penetrate the market. He notes that NIO's ES8, the company's first mass-produced model, has best-in-class specifications but a lower price, partly due to local manufacturing subsidies, the absence of customs duties and reduced taxes.
10/09/18
JPMS
10/09/18
INITIATION
Target $7.5
JPMS
Neutral
NIO Inc. initiated with a Neutral at JPMorgan
JPMorgan analyst Nick Lai started NIO Inc. with a Neutral rating and $7.50 price target. The analyst wants to see a track record of execution before getting more constructive on the shares and adds that potential further capital raising could also be a risk before the company turns a profit in 2021.
10/08/18
10/08/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. BARCLAYS BOOSTS GE TO OVERWEIGHT: Barclays analyst Julian Mitchell upgraded General Electric (GE) to Overweight from Equal Weight with an unchanged price target of $16. The analyst said that while he does not yet know the magnitude of the 2018 guidance cuts, his talks with investors suggest they are braced for earnings per share of 75c for 2018, free cash flow of 50c, and a dividend cut of 75%-plus. PIPER JAFFRAY CUTS IROBOT TO NEUTRAL: Piper Jaffray analyst Troy Jensen downgraded iRobot (IRBT) to Neutral with an unchanged price target of $90. The analyst continues to believe the robotic vacuum market is in a secular uptrend and that iRobot will "maintain its dominant position in the market." However, Jensen has become "incrementally more concerned" with the stock's valuation following the year-to-date outperformance. NIO INITIATED BY MULTIPLE FIRMS: Deutsche Bank analyst Vincent Ha started NIO Inc. (NIO) with a Buy rating and $9.50 price target. The company's electric vehicles in China are "prepared to challenge the status quo," Ha said. Additionally, Wolfe Research initiated NIO with an Outperform and $8 price target, and Goldman Sachs started NIO Inc. with a Neutral rating and $6.56 price target. GOLDMAN BOOSTS SQUARE PRICE TARGET: Goldman Sachs analyst James Schneider increased his price target on Square (SQ) to $108 from $77 after raising his 2018-20 revenue estimates given he now sees more upside than in his prior estimates across a range of Square's business lines. He also raised his multiple on the stock, saying that Square is one of the only companies sustaining over 50% revenue growth while simultaneously delivering substantial margin expansion. Schneider, who model about 2.5X faster growth than PayPal (PYPL) and about 5X faster growth than merchant acquirers for Square through 2020, reiterated Buy rating on Square shares. CITI BOOSTS APPLE PRICE TARGET: Citi analyst Jim Suva raised his price target for Apple (AAPL) to $265 and reiterated a Buy rating on the shares. Suva increased his financial model for Apple to reflect higher average selling prices and stronger gross margins given the consumer preference for higher memory configurations of iPhones coupled with falling memory prices.
GLD SPDR Gold Shares
$115.24

(0.00%)

JNUG Direxion Daily Jr Gld Mnrs Bull 3X Shrs
$8.94

(0.00%)

GDX VanEck Vectors Gold Miners ETF
$19.75

(0.00%)

08/15/18
RBCM
08/15/18
DOWNGRADE
Target $1.4
RBCM
Underperform
New Gold downgraded to Underperform at RBC Capital on eroding cash flow
As reported earlier, RBC Capital analyst Dan Rollins downgraded New Gold to Underperform from Sector Perform and lowered his price target to $1.40 from $3.50. The analyst cites elevated financial leverage and "material" reduction in free cash flow, along with continued risk related to Rainy River mine ramp. Rollins believes that although New Gold has underperformed the broader gold mining ETF GDX by 30%, it will continue to underperform until its risks diminish.
HD Home Depot
$192.24

(0.00%)

10/15/18
WEDB
10/15/18
NO CHANGE
Target $115
WEDB
Neutral
Lowe's price target raised to $115 from $105 at Wedbush
Wedbush analyst Seth Basham raised his price target for Lowe's (LOW) to $115 from $105 as he expects near-term progress on key initiatives to add confidence to the story, while the roadmap to much higher earnings power should come at the company's December 12 Analyst and Investor Conference. While execution risk should not be minimized in improving large retail organizations, CEO Marvin Ellison's success in turning around retail fundamentals at Home Depot (HD) bolsters the likelihood that he can execute a very similar plan at Lowe's, with material top- and bottom-line growth despite this period of investment and change, along with strong competition from Home Depot and Amazon (AMZN), he contends. Basham reiterates a Neutral rating on Lowe's shares.
10/02/18
BOFA
10/02/18
NO CHANGE
Target $132
BOFA
Buy
Lowe's added to the top investment ideas 'US1 List' at BofA/Merrill
BofA/Merrill analyst Elizabeth Suzuki kept her Buy rating and $132 price target on Lowe's (LOW) but added the stock to her top investment ideas "US1 List". The analyst believes that the opportunity to improve the company's comps and operating margins closer to those of top rival Home Depot (HD) has "just arrived" and that its earnings growth could double that of Home Depot as the new management works to improve sales productivity. Suzuki adds that expectations of a peak in existing home sales does not coincide with home improvement activity - rather the Private Fixed Residential Investment where home improvement is a key component peaks about 4 years later.
09/28/18
09/28/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. CITI CUTS TESLA TO SELL: Citi analyst Itay Michaeli downgraded Tesla (TSLA) to Sell from Neutral and lowered his price target for the shares to $225 from $356. The analyst is making a "risk/reward call" into the outcome of the SEC lawsuit against CEO Elon Musk. In a scenario where the suit leads to Musk's exit, the analyst says there is "little question" that the departure would likely cause harm to Tesla's brand, stakeholder confidence and fundraising. This would increase the risk of triggering a "downward confidence spiral" given the state of Tesla's balance sheet, Michaeli said. Even if Musk were to stay on after settling or prevailing, the analyst believes the "reputational harm" from the suit "might still prevent the stock from immediately returning to 'normal.'" SUNTRUST UPGRADES LOWE'S TO BUY: SunTrust analyst Keith Hughes upgraded Lowe's (LOW) to Buy from Hold and raised his price target to $138 from $110. The analyst cites the company's latest Q2 earnings and the analyst meeting with its management suggesting an "internally focused" turnaround progressing at a "consistent pace" over the next 2-3 years. Hughes adds that even though the stock has recently turned higher, it could rise as much as 50% if the company could reclaim just half of the SG&A difference with Home Depot (HD). STIFEL STARTS ZYNGA WITH A BUY: Stifel analyst Drew Crum initiated Zynga (ZNGA) with a Buy rating and a price target of $5. The analyst cites the "favorable industry for mobile gaming", with annualized mobile gaming revenue expected to increase by 17%. Crum also cites his expectations of greater visibility on its game pipeline and further opportunities to improve adjusted EBITDA. WELLS DOWNGRADES CONTAINERSHIP NAMES: Wells Fargo analyst Michael Webber downgraded the Box Lessor and Containership group saying headwinds from both the International Maritime Organization 2020 fuel regulations and the impact of tariffs have created "significant downside risks" for the stocks. He downgraded Triton International (TRTN), CAI International (CAI) and Costamare (CMRE), all to Market Perform from Outperform, and cut Seaspan (SSW) and Textainer (TGH) to Underperform from Market Perform. He kept a Market Perform rating on Matson (MATX) with an unchanged price target of $35. EVERCORE BOOSTS NVIDIA PRICE TARGET: Evercore ISI analyst C.J. Muse said he believes investors are now more appreciative of Nvidia's (NVDA) opportunity in creating the AI industry standard and the company's "positive feedback loop" within deep learning. Longer-term, he sees tremendous growth opportunities led by the new Turing architecture, which further entrenches Nvidia's high-end gaming moat and presents a "meaningful" opportunity in Inference, Muse said. The analyst, who sees Nvidia being poised to grow EPS at a 30-35% CAGR through 2020 and beyond, raised his price target on the stock to $400 from $300 and kept an Outperform rating on the shares.
09/17/18
JEFF
09/17/18
NO CHANGE
JEFF
Buy
Hurricane checks positive for Home Depot, Lowe's, says Jefferies
Jefferies analyst Jonathan Matuszewskis says his channel checks indicate strong demand for hurricane preparedness products at both Home Depot (HD) and Lowe's (LOW). The analyst, who spent time speaking with sales associates at all the Home Depot and Lowe's locations within a 175-mile radius of Wilmington, North Carolina, continues to believe Lowe's will be the largest beneficiary given its exposure to Wilmington. The comp benefit this quarter could be upwards of 50 basis points with moderating tailwinds into Q4 of fiscal 2019 and Q1 of fiscal 2020 as repairs are made, Matuszewskis tells investors in a research note. He keeps Buy ratings on both Lowe's and Home Depot.
USO United States Oil Fund
$15.12

(0.00%)

CHK Chesapeake
$4.45

(0.00%)

10/04/18
MSCO
10/04/18
INITIATION
Target $5
MSCO
Equal Weight
Chesapeake initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Devin McDermott initiated Chesapeake Energy with an Equal Weight rating and $5 price target, stating that while the company has come a long way streamlining its asset base and deleveraging, the stock's upside now hinges on execution in the Powder River Basin. He sees a valuation range of $4-$10 depending on its level of success in that execution, McDermott tells investors.
09/25/18
RHCO
09/25/18
DOWNGRADE
Target $5
RHCO
Hold
Chesapeake downgraded to Hold at SunTrust on valuation
As reported earlier, SunTrust analyst Neal Dingmann downgraded Chesapeake to Hold from Buy and lowered his price target to $5 from $6. The analyst notes that while the company may be approaching an inflection point where cash flows will outpace spending, the turnaround could be pushed back to 2020 rather than 2019 as it takes the time to develop its prized asset Powder River Basin, or PRB. Dingmann believes that the PRB output could double over the next year, adding that while the company the company has made progress in reducing debt, its leverage remains higher than that of its peer group.
09/24/18
RHCO
09/24/18
DOWNGRADE
RHCO
Hold
Chesapeake downgraded to Hold from Buy at SunTrust
08/16/18
WOLF
08/16/18
DOWNGRADE
WOLF
Underperform
Chesapeake downgraded to Underperform from Peer Perform at Wolfe Research

TODAY'S FREE FLY STORIES

GM

General Motors

$35.57

0.9 (2.60%)

15:59
10/13/19
10/13
15:59
10/13/19
15:59
Periodicals
UAW boosting strike pay as General Motor walkout continues, Reuters says »

The United Auto Workers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

MRK

Merck

$84.31

0.6 (0.72%)

, JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

15:49
10/13/19
10/13
15:49
10/13/19
15:49
Periodicals
Congo to start using Johnson & Johnson Ebola vaccine next month, Reuters says »

Health authorities in…

MRK

Merck

$84.31

0.6 (0.72%)

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 23

    Oct

  • 29

    Oct

  • 06

    Nov

  • 24

    Jan

  • 24

    Jan

  • 14

    Mar

HMTV

Hemisphere Media

$11.70

0.05 (0.43%)

15:48
10/13/19
10/13
15:48
10/13/19
15:48
Initiation
Hemisphere Media initiated  »

Hemisphere Media…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$36.11

0.31 (0.87%)

15:37
10/13/19
10/13
15:37
10/13/19
15:37
Hot Stocks
Pfizer presents Phase 3 data for Abrocitinib in moderate to severe AD »

Pfizer announced complete…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

CNCE

Concert Pharmaceuticals

$5.85

(0.00%)

15:29
10/13/19
10/13
15:29
10/13/19
15:29
Hot Stocks
Concert Pharmaceuticals presents Phase 2 data in Alopecia Areata »

Concert Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$76.14

0.38 (0.50%)

15:23
10/13/19
10/13
15:23
10/13/19
15:23
Hot Stocks
Incyte announces 52-week results from Phase 2 study of Ruxolitinib cream »

Incyte announced 52-week…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

LLY

Eli Lilly

$108.37

1.54 (1.44%)

14:15
10/13/19
10/13
14:15
10/13/19
14:15
Hot Stocks
Eli Lilly says Taltz met co-primary endpoints in Phase 3 plaque psoriasis study »

Eli Lilly announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

PCG

PG&E

$8.08

0.3 (3.86%)

07:46
10/13/19
10/13
07:46
10/13/19
07:46
Hot Stocks
PG&E says all customers impacted by safety shutoffs now have power »

Pacific Gas and Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

  • 07

    Jan

BNTX

BioNTech

$13.50

-0.85 (-5.92%)

, VIR

Vir Biotechnology

$14.06

(0.00%)

07:18
10/13/19
10/13
07:18
10/13/19
07:18
On The Fly
Opening Day: BioNTech raises $150M in smaller than expected IPO »

BioNTech (BNTX) raised…

BNTX

BioNTech

$13.50

-0.85 (-5.92%)

VIR

Vir Biotechnology

$14.06

(0.00%)

HBT

HBT Financial

$15.56

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

KRAT

Karat Packaging

$0.00

(0.00%)

POST

Post Holdings

$101.19

1.94 (1.95%)

IPHA

Innate Pharma

$0.00

(0.00%)

BRBR

BellRing Brands

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 17

    Oct

  • 17

    Oct

ANGO

AngioDynamics

$14.54

0.12 (0.83%)

, BAYRY

Bayer

$0.00

(0.00%)

04:55
10/13/19
10/13
04:55
10/13/19
04:55
Conference/Events
Healthcare Made Practical to hold a symposium »

Symposium on Clinical…

ANGO

AngioDynamics

$14.54

0.12 (0.83%)

BAYRY

Bayer

$0.00

(0.00%)

BSX

Boston Scientific

$38.22

0.22 (0.58%)

BTG

B2Gold

$3.25

-0.2 (-5.80%)

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

LLY

Eli Lilly

$108.37

1.54 (1.44%)

MDT

Medtronic

$107.61

0.24 (0.22%)

PFE

Pfizer

$36.11

0.31 (0.87%)

PHG

Philips

$42.88

0.99 (2.36%)

TRUMY

Terumo

$0.00

(0.00%)

VAR

Varian Medical

$110.78

1.84 (1.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 29

    Oct

  • 06

    Nov

  • 06

    Nov

  • 13

    Nov

AMBA

Ambarella

$53.62

1.25 (2.39%)

, ON

ON Semiconductor

$18.74

0.67 (3.71%)

09:31
10/12/19
10/12
09:31
10/12/19
09:31
On The Fly
Week in Review: How Trump's policies moved stocks »

Catch up on the top…

AMBA

Ambarella

$53.62

1.25 (2.39%)

ON

ON Semiconductor

$18.74

0.67 (3.71%)

AAPL

Apple

$236.21

6.12 (2.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 28

    Oct

  • 30

    Oct

BBBY

Bed Bath & Beyond

$12.98

0.89 (7.36%)

, AMZN

Amazon.com

$1,730.79

11.115 (0.65%)

08:48
10/12/19
10/12
08:48
10/12/19
08:48
Periodicals
Bed Bath & Beyond not a bargain, Barron's says »

While Bed Bath &…

BBBY

Bed Bath & Beyond

$12.98

0.89 (7.36%)

AMZN

Amazon.com

$1,730.79

11.115 (0.65%)

TGT

Target

$111.86

1.29 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 21

    Nov

SNE

Sony

$58.16

0.83 (1.45%)

, MSFT

Microsoft

$139.62

0.52 (0.37%)

08:39
10/12/19
10/12
08:39
10/12/19
08:39
Periodicals
Activision, Take-Two to benefit from next videogame cycle, Barron's says »

Sony (SNE) has announced…

SNE

Sony

$58.16

0.83 (1.45%)

MSFT

Microsoft

$139.62

0.52 (0.37%)

ATVI

Activision Blizzard

$54.80

1.1 (2.05%)

TTWO

Take-Two

$122.42

0.02 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 23

    Oct

  • 26

    Oct

  • 27

    Oct

  • 29

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 13

    Nov

  • 21

    Nov

  • 21

    Nov

K

Kellogg

$62.14

-0.27 (-0.43%)

08:27
10/12/19
10/12
08:27
10/12/19
08:27
Periodicals
Kellogg stock looking like worth 'snacking on,' Barron's says »

Kellogg's stock fell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

, ITW

Illinois Tool Works

$154.56

4.68 (3.12%)

08:20
10/12/19
10/12
08:20
10/12/19
08:20
Periodicals
J&J, Pentair among stocks with sage, growing dividends, Barron's says »

Investors seeking yield…

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

ITW

Illinois Tool Works

$154.56

4.68 (3.12%)

NUE

Nucor

$52.69

2.48 (4.94%)

PNR

Pentair

$37.33

1.215 (3.36%)

GWW

Grainger

$305.24

16.49 (5.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 25

    Oct

ANGO

AngioDynamics

$14.54

0.12 (0.83%)

, BAYRY

Bayer

$0.00

(0.00%)

04:55
10/12/19
10/12
04:55
10/12/19
04:55
Conference/Events
Healthcare Made Practical to hold a symposium »

Symposium on Clinical…

ANGO

AngioDynamics

$14.54

0.12 (0.83%)

BAYRY

Bayer

$0.00

(0.00%)

BSX

Boston Scientific

$38.22

0.22 (0.58%)

BTG

B2Gold

$3.25

-0.2 (-5.80%)

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

LLY

Eli Lilly

$108.37

1.54 (1.44%)

MDT

Medtronic

$107.61

0.24 (0.22%)

PFE

Pfizer

$36.11

0.31 (0.87%)

PHG

Philips

$42.88

0.99 (2.36%)

TRUMY

Terumo

$0.00

(0.00%)

VAR

Varian Medical

$110.78

1.84 (1.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 29

    Oct

  • 06

    Nov

  • 06

    Nov

  • 13

    Nov

THTX

Theratechnologies

$3.76

0.01 (0.27%)

18:32
10/11/19
10/11
18:32
10/11/19
18:32
Hot Stocks
Theratechnologies: Tesamorelin study results on NAFLD published in Lancet HIV »

Theratechnologies is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$20.76

0.76 (3.80%)

18:26
10/11/19
10/11
18:26
10/11/19
18:26
Hot Stocks
Wendy's CEO: We are really focused on the long term »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

  • 13

    Nov

GOOG

Alphabet

$1,213.86

5.88 (0.49%)

, GOOGL

Alphabet Class A

$1,214.62

6.18 (0.51%)

18:25
10/11/19
10/11
18:25
10/11/19
18:25
Periodicals
Breaking Periodicals news story on Alphabet, Alphabet Class A »

DOJ to more closely…

GOOG

Alphabet

$1,213.86

5.88 (0.49%)

GOOGL

Alphabet Class A

$1,214.62

6.18 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

BA

Boeing

$374.90

3.97 (1.07%)

18:22
10/11/19
10/11
18:22
10/11/19
18:22
Hot Stocks
Boeing board separates CEO and Chairman roles »

Boeing announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$296.34

3.1 (1.06%)

18:08
10/11/19
10/11
18:08
10/11/19
18:08
Hot Stocks
White House releases letter from China's Xi to President Trump »

The White House posted on…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$296.34

3.1 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVA

Avista

$48.73

0.51 (1.06%)

17:40
10/11/19
10/11
17:40
10/11/19
17:40
Hot Stocks
Avista reaches all-party settlement in Idaho general rate case »

Avista and all parties to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 10

    Nov

AMC

AMC Entertainment

$9.21

0.055 (0.60%)

17:10
10/11/19
10/11
17:10
10/11/19
17:10
Hot Stocks
AMC Entertainment appoints Sean Goodman CFO »

AMC Entertainment (AMC)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCEHY

Tencent

$0.00

(0.00%)

, ATVI

Activision Blizzard

$54.80

1.1 (2.05%)

17:04
10/11/19
10/11
17:04
10/11/19
17:04
Hot Stocks
Riot tells 'League of Legends' players, casters to not discuss politics on air »

John Needham, Global Head…

TCEHY

Tencent

$0.00

(0.00%)

ATVI

Activision Blizzard

$54.80

1.1 (2.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 07

    Nov

CLNC

Colony Credit Real Estate

$14.02

0.12 (0.86%)

16:55
10/11/19
10/11
16:55
10/11/19
16:55
Syndicate
Colony Credit Real Estate files to sell 47.94M shares of Class A common stock »

The offering is being…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.